{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2016"],"condition":["metastatic colorectal cancer"],"disease":["Metastatic Colorectal Cancer"],"study_type":["Other"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2637433"],"location":["Japan"],"study_start_month":["5"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases: a retrospective study(WJOG4407GSS)","description":"Primary outcome(s): Correlation between morphologic response and progression-free survival","dates":{"creation":"2016-05-15"},"accession":"2637433","cross_references":{"Japan Primary Registries Network":["JPRN-UMIN000022171"]}}